Resources Contact Us Home
Polynucleotides encoding myostatin binding agents

Image Number 6 for United States Patent #7803923.

The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity.

  Recently Added Patents
Heat shield and laminated glass
Vanadium, cobalt and strontium additives for use in aluminum back solar cell contacts
Managing a spinlock indicative of exclusive access to a system resource
Packaging for socks
Method and system for fail-safe call survival
Electric motor
Combination therapy to enhance NK cell mediated cytotoxicity
  Randomly Featured Patents
snRNA gene-like transcriptional units and uses thereof
Method of operating an engine at idle speed for operational diagnosis of a purge valve
Article for identifying pieces of timber
In situ method for processing a perishable product
Method in cultivation of plants and planting them, as well as means for carrying out the method
Plasma display panel with energy recovery circuit and driving method thereof
Method for making a cellulosic material fire-resistant
Stringed instrument with embedded DSP modeling
Applicator device
Digitized audio data attachment to text message for electronic mail